Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Meijer

Showing results (341-350 of 378) with videos related to

Pageof 38
Sort By:
Experimental Hematology & Oncology|December 1, 2023
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary diseaseMireia Mato Prado, Jisce R Puik, Leandro Castellano, et al.
Cancers|September 23, 2022
Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant TherapiesSanne J M Hoefnagel, Willem J Koemans, Hina N Khan, et al.
Journal of Clinical Pharmacology|July 17, 2001
Immunological and molecular analysis of the sentinel lymph node: a potential approach to predict outcome, tailor therapy, and optimize parameters for tumor vaccine developmentS L Meijer, A Dols, H M Hu, et al.
Histopathology|June 19, 2026
Diagnostic impact and reproducibility of p53 immunohistochemistry in Barrett's oesophagus: results of the Dutch Esophageal Pathology Panel (DEPP)Ylva A Weeda, Sarah M Issa, Hans Halfwerk, et al.
Therapeutic Advances in Medical Oncology|July 5, 2022
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)Charlotte I Stroes, Sandor Schokker, Mohammed Khurshed, et al.
Breast Cancer Research and Treatment|June 25, 2015
Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approachT J A Dekker, S ter Borg, G K J Hooijer, et al.
Breast Cancer Research and Treatment|June 5, 2015
Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approachT J A Dekker, S ter Borg, G K J Hooijer, et al.
Gastroenterology|June 11, 2018
microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of PatientsLuigi Mari, Sanne J M Hoefnagel, Domenico Zito, et al.
Communications Biology|January 12, 2022
Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuitsErnesto Rodriguez, Kelly Boelaars, Kari Brown, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 2, 2020
Multicenter study on the diagnostic performance of multiframe volumetric laser endomicroscopy targets for Barrett's esophagus neoplasia with histopathology correlationM R Struyvenberg, A J de Groof, A Kahn, et al.
Pageof 38

Showing results (341-350 of 378) with videos related to

Sort By:
Pageof 38
Experimental Hematology & Oncology|December 1, 2023
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary diseaseMireia Mato Prado, Jisce R Puik, Leandro Castellano, et al.
Cancers|September 23, 2022
Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant TherapiesSanne J M Hoefnagel, Willem J Koemans, Hina N Khan, et al.
Journal of Clinical Pharmacology|July 17, 2001
Immunological and molecular analysis of the sentinel lymph node: a potential approach to predict outcome, tailor therapy, and optimize parameters for tumor vaccine developmentS L Meijer, A Dols, H M Hu, et al.
Histopathology|June 19, 2026
Diagnostic impact and reproducibility of p53 immunohistochemistry in Barrett's oesophagus: results of the Dutch Esophageal Pathology Panel (DEPP)Ylva A Weeda, Sarah M Issa, Hans Halfwerk, et al.
Therapeutic Advances in Medical Oncology|July 5, 2022
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT)Charlotte I Stroes, Sandor Schokker, Mohammed Khurshed, et al.
Breast Cancer Research and Treatment|June 25, 2015
Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approachT J A Dekker, S ter Borg, G K J Hooijer, et al.
Breast Cancer Research and Treatment|June 5, 2015
Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approachT J A Dekker, S ter Borg, G K J Hooijer, et al.
Gastroenterology|June 11, 2018
microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of PatientsLuigi Mari, Sanne J M Hoefnagel, Domenico Zito, et al.
Communications Biology|January 12, 2022
Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuitsErnesto Rodriguez, Kelly Boelaars, Kari Brown, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 2, 2020
Multicenter study on the diagnostic performance of multiframe volumetric laser endomicroscopy targets for Barrett's esophagus neoplasia with histopathology correlationM R Struyvenberg, A J de Groof, A Kahn, et al.
Pageof 38